1- Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Gül O, Eroğlu M, Özok U. Int Urol Nephrol. 2001;32:433-436. 2- Repair of bilateral complete ureteral ligation that occured during hysterectomy. Gül O, Eroğlu M, Beyribey S. Int Uro Nephrol. 2001;32:341-341. Eroğlu M, Irmak S, Acar A, Denkbaş EB. Int J Pharm. 2002 Mar 20;235(1-2):51-9. 3- Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer. Eroğlu M, Irmak S, Acar A, Denkbaş EB. Int J Pharm. 2002 Mar 20;235(1-2):51-9. 4- Giant ureteral stone associated with partial ureteral duplication. Eroglu M, Unsal A, Cimentepe E, Bakirtas H. Int Urol Nephrol. 2003;35(4):485-7. 5- Mytomycin-C-loaded Alginate Carriers for Bladder Cancer Chemotherapy. Denkbaş EB, Özdemir N, Öztürk E, Eroğlu M, Acar A. J Bioact compat pol. 2004;19:33-44. 6- Is early forceps application necessary in the treatment of distal ureteral stone with dye-laser and pneumatic lithotripsy? Kiper A, Tuygun C, İmamoğlu MA, Yiğitbaşı O, Eroğlu M. Urologia. 2004;71: 1-3. 7- Propofol attenuates reperfusion injury after testicular torsion and detorsion. Unsal A, Devrim E, Guven C, Eroglu M, Durak I, Bozoklu A, Balbay MD. World J Urol. 2004 Dec;22(6):461-5. 8- Mitomycin-C loaded alginate carriers for bladder cancer chemotherapy: in vivo studies. Eroğlu M, Öztürk E, Doğan AI, Acar A, Güzel M, Özdemir N, Denkbaş EB.J Bioact compat pol. 2005; 20: 197-208 9- Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma. Eroğlu M, Unsal A, Bakirtaş H, Tekdoğan U, Ataoğlu O, Balbay MD. Scand J Urol Nephrol. 2005;39(3):222-5. 10- Malignant fibrous histiocytoma arising from the renal capsule. Eroğlu M, Bakirtaş H, Cimentepe E, Unsal A, Ataoğlu O, Balbay MD. Urol Int. 2005;75(4):368-70. 11- Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates. Ozok U, Eroglu M, Imamoglu A, Bakirtaş H, Güvence N, Kiper A. J Endourol. 2005 Dec;19(10):1185-7. 12- Rib resection for live-donor nephrectomy. Eroğlu M, Güvence N, Kiper A, Bakirtaş H, Ozok U, Imamoğlu A. Int Urol Nephrol. 2005;37(4):675-9. 13- Protective role of natural antioxidant supplementation on testicular tissue after testicular torsion and detorsion. Unsal A, Eroglu M, Avci A, Cimentepe E, Guven C, Derya Balbay M, Durak I. Scand J Urol Nephrol. 2006;40(1):17-22. 14- Surgical approach to cases with multiple renal arteries in renal transplantation. Bakirtas H, Guvence N, Eroglu M, Ure M, Ozok HU, Karabulut I, Gul O, Banli O. Urol Int. 2006;76(2):169-72. 15- Chitosan-coated alginate microspheres for embolization and/or chemoembolization: in vivo studies. Eroğlu M, Kurşaklioğlu H, Misirli Y, Iyisoy A, Acar A, Işin Doğan A, Denkbaş EB. J Microencapsul. 2006 Jun;23(4):367-76. 16- Contractile responses of rabbit bladder neck to adrenaline, acetylcholine and papaverine after doxazosin treatment. Eroglu M, Sezgin A, Semercioz A, Metin A, Kandirali E, Ali Onur M. Int Urol Nephrol. 2007;39(1):137-41. 17- Rapid communication: renal apoptosis after shockwave application in rabbit model. Cimentepe E, Eroglu M, Oztürk U, Bayrak O, Tuygun C, Acar A, Uzüm N, Unsal A. J Endourol. 2006 Dec;20(12):1091-5. 18- No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population. Onen IH, Konac E, Eroglu M, Guneri C, Biri H, Ekmekci A. Mol Biol Rep. 2008 Mar;35(1):17-22. 19- Isolated renal hydatic cyst; from an unusual course to diagnosis. Metin A, Kandirali E, Semerciöz A, Eroğlu M, Uysal B, Dadas E. Int Urol Nephrol. 2007;39(1):19-21. 20- The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population. Onen IH, Ekmekci A, Eroglu M, Polat F, Biri H. DNA Cell Biol. 2007 Feb;26(2):100-7. 21- Ureterovesical malignancy following renal transplantation: a case report Bakırtaş H. Güvence N. Özok HU. Üre M, Eroğlu M. Transplant Proc. 2007;39(10):3474-76. 22- Is second-line enuretic alarm therapy after unsuccessful pharmacotherapy superior to first-line therapy in the treatment of monosymptomatic nocturnal enuresis? Tuygun C, Eroglu M, Bakirtas H, Gucuk A, Zengin K, Imamoglu A. Urol Int. 2007;78(3):260-3. 23- The effects of shock waves on lung tissue in acute period: an in vivo study. Eroglu M, Cimentepe E, Demirag F, Unsal E, Unsal A. Urol Res. 2007 Jun;35(3):155-60. 24- PERSISTENT Müllerian duct syndrome associated with transverse testicular ectopia: report of two cases. Ozturk H, Eroglu M, Ozturk H, Uzunlar AK, Okur H. Fetal Pediatr Pathol. 2007 Jan-Feb;26(1):41-6. 25- Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer. Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H. Exp Biol Med (Maywood). 2008 Dec;233(12):1608-14. 26- Time-dependent changes in biomechanical properties of four different synthetic materials in a rabbit model and the importance in respect to sling surgery. Atmaca AF, Serefoğlu EC, Eroğlu M, Gürdal M, Metin A, Kayigil O. Urol Int. 2008;81(4):456-61. 27- Nephron-sparing surgery: the effect of surface cooling and temporary renal artery occlusion on renal function. Bakirtas H, Eroglu M, Naldoken S, Akbulut Z, Tekdogan UY. Urol Int. 2009;82(1):24-7. 28- Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. Eroglu M, Yilmaz N, Yalcinkaya S, Ay N, Aydin O, Sezer C. Kaohsiung J Med Sci. 2013 Jul;29(7):368-73. 29- Comparison of ultrasonic and pneumatic intracorporeal lithotripsy techniques during percutaneous nephrolithotomy. Karakan T, Diri A, Hascicek AM, Ozgur BC, Ozcan S, Eroglu M. ScientificWorldJournal. 2013 Aug 18;2013:604361. doi: 10.1155/2013/604361. eCollection 2013. 30- Re: combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: O. Kehinde, M. Al-Maghrebi, M. Sheikh and J. T. Anim J Urol 2013; 189: 911–915. Ozgur BC, Sarici H, Doluoglu OG, Telli O, Eroglu M. J Urol. 2014 Mar;191(3):871-3. doi: 10.1016/j.juro.2013.09.090. Epub 2013 Dec 17. No abstract available. 31- Diminished arylesterase enzyme activity and total thiol levels in bladder cancer patients. Aydin O, Yacinkaya S, Eren E, Ergin M, Eroglu M, Yilmaz N. Clin Lab. 2013;59(11-12):1231-7. 32- Positive correlation of serum parathormone and prostate specific antigen levels in prostate cancer. Aydin O, Eren E, Yalcinkaya S, Yilmaz N, Eroglu M, Ellidag HY. Bratisl Lek Listy. 2014;115(3):171-4. 33- Comparison of herbal-based and synthetic hemostatic agents for efficacy on a rat partial nephrectomy model. Experimental study. Bagcioglu M, Huri E, Dadali M, Astarci HM, Sargon MF, Eroglu M. Saudi Med J. 2014 Jan;35(1):33-8. 34- Pediatric extracorporeal shock wave lithotripsy: Multi-institutional results. Ozgür BC, Irkilata L, Ekici M, Hoscan MB, Sarici H, Yücetürk CN, Karakan T, Atilla MK, Hasçiçek AM, Eroglu M. Urologia. 2014 Feb 26;0(0):0. doi: 10.5301/urologia.5000053. [Epub ahead of print] 35- Serum omentin level in patients with prostate cancer. Uyeturk U, Sarıcı H, Kın Tekce B, Eroglu M, Kemahlı E, Uyeturk U, Gucuk A. Med Oncol. 2014 Apr;31(4):923. doi: 10.1007/s12032-014-0923-6. Epub 2014 Mar 23. 36- The effect of sildenafil and udenafil on testicular damage following ischemia-reperfusion injury in rats. Ozgür BC, Telli O, Yuceturk CN, Sarici H, Ozer E, Surer H, Kılınc AS, Hucumenoglu S, Eroglu M. J Urol. 2014 Oct;192(4):1272-7. doi: 10.1016/j.juro.2014.04.011. Epub 2014 Apr 15. 37- The prevalence of overactive bladder syndrome and urinary incontinence in a Turkish women population; associated risk factors and effect on Quality of life. Sarici H, Ozgur BC, Telli O, Doluoglu OG, Eroglu M, Bozkurt S. Urologia. 2014 Apr 22;0(0):0. doi: 10.5301/uro.5000057. [Epub ahead of print] 38- How many times should the uroflowmetry be repeated before making a treatment decision in the elderly males? Ozgur BC, Sarici H, Yuceturk CN, Karakan T, Eroglu M. J Pak Med Assoc. 2014 Mar;64(3):252-5. 39- Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: a multicenter retrospective analysis. Ozgür BC, Köseoğlu E, Arık Aİ, Sarıcı H, Bilgin O, Yücetürk CN, Ozer E, Güven EO, Telli O, Atan A, Eroğlu M. Kaohsiung J Med Sci. 2014 Jul;30(7):371-5. doi: 10.1016/j.kjms.2014.02.011. Epub 2014 Apr 40- Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6. Sarici H, Telli O, Yigitbasi O, Ekici M, Ozgur BC, Yuceturk CN, Eroglu M. Can Urol Assoc J. 2014 May;8(5-6):E342-6. doi: 10.5489/cuaj.1499. 41- Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer? Eroglu M, Doluoglu OG, Sarici H, Telli O, Ozgur BC, Bozkurt S. Korean J Urol. 2014 Jun;55(6):395-9. doi: 10.4111/kju.2014.55.6.395. Epub 2014 Jun 16. 42- A population-based study of factors associated with nocturia in reproductive-aged Turkish women. Sarici H, Telli O, Ozgür BC, Doluoğlu OG, Eroğlu M, Bozkurt S. Korean J Urol. 2014 Jun;55(6):405-10. doi: 10.4111/kju.2014.55.6.405. Epub 2014 Jun 16. 43- Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia. Yalçınkaya S, Eren E, Eroglu M, Aydin O, Yilmaz N. Adv Clin Exp Med. 2014 May-Jun;23(3):441-6. 44- Can circumcision be a risk factor in premature ejaculation? Telli O, Karakan T, Sarici H, Kabar M, Ozgur BC, Eroglu M. Revista Internacional de Andrología. 2014;12(3):100-103 45- Ürothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes. Telli O, Sarici H, Ozgur BC, Doluoglu OG, Sunay MM, Bozkurt S, Eroglu M. Kaohsiung J Med Sci. 2014 Sep;30(9):466-70. doi: 10.1016/j.kjms.2014.02.017. Epub 2014 Apr 24. 46- Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy? Telli O, Sarici H, Ekici M, Ozgur BC, Doluoglu OG, Eroglu M, Telli TA. Ther Adv Med Oncol. 2015 Mar;7(2):63-7

Prostate Cancer Kidney Cancer Bladder Cancer Robotic Surgery

: (312) 305 19 70

: muzaffereroglu@hacettepe.edu.tr